Citation Impact
Citing Papers
Subcutaneous Adjusted-Dose Unfractionated Heparin vs Fixed-Dose Low-Molecular-Weight Heparin in the Initial Treatment of Venous Thromboembolism
2004
Measurement and Interpretation of the Ankle-Brachial Index
2012
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
The natural history and epidemiology of venous thrombosis
1994
Prevention of Deep Vein Thrombosis after Elective Hip Surgery
1991
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
2005 Standout
The controversy of managing calf vein thrombosis
2011
What is “quality of evidence” and why is it important to clinicians?
2008 Standout
Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis
1992
Modified forms of low density lipoprotein affect platelet aggregation
1989
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Non-specific low back pain
2016 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Nutrition and platelet function in atherogenesis
1987
Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status
2004
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Malondialdehyde regulates glucose-stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway
2013
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
2009 Standout
The Clinical Course of Pulmonary Embolism
1992 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
How were new medicines discovered?
2011 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Disseminated Intravascular Coagulation
1999 Standout
Heparin
1991
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Hemorrhagic Complications of Anticoagulant Treatment
1998
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Role of oxidized low density lipoprotein in atherogenesis.
1991 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin
1991
Management of Deep Vein Thrombosis in Spinal Cord Injury
1992
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
1992
The Case for Managing Calf Vein Thrombi With Duplex Surveillance and Selective Anticoagulation
2010
Risk of complications during intravenous heparin therapy.
1982
Subcutaneous administration of heparin a randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis
1982
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Interventional Therapies, Surgery, and Interdisciplinary Rehabilitation for Low Back Pain
2009
Two Daily Subcutaneous Injections of Fragmin as Compared with Intravenous Standard Heparin in the Treatment of Deep Venous Thrombosis (DVT)
1990
Hemorrhagic Complications of Anticoagulant Treatment
1992
In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
1990
Epidemiology of Peripheral Artery Disease
2015 Standout
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis
1987
Disseminated intravascular coagulation due to malignancy.
1990
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.
1987
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Calf Deep Venous Thrombosis
1988
Hemorrhagic Complications of Anticoagulant Treatment
1995
Treatment of Venous Thromboembolism
1999
Clinical relevance of distal deep vein thrombosis. Review of literature data.
2006
Venous thrombosis: a multicausal disease
1999 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Immunogenicity of malondialdehyde-modified low density lipoproteins
1987
Platelet activation by plasma lipoproteins
1987
Deep Venous Thrombosis and Pulmonary Embolism in Trauma Patients
1988
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers
1986
Works of Nigel Jones being referenced
PERCUTANEOUS ENDOSCOPIC LASER DISCECTOMY
2000
An objective study of alternative methods of heparin administration
1980
Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia
1981
Comparison of Lower Limb Arterial Assessments Using Color-Duplex Ultrasound and Ankle/Brachial Pressure Index Measurements
1996